AMED Latest Quarter's Earnings
Announce Date 02/26/2025
EPS Normalized Actual $0.96 (Miss by $-0.09)
EPS GAAP Actual $0.96 (Miss by $-0.09)
Revenue Actual $0.598052B
Revenue Surprise Beat by $598.052M
Upcoming Quarter's Earnings
Announce Date 03/30/2025 (Pre-Market)
EPS Normalized Estimate $1.08
EPS GAAP Estimate $1.08
Revenue Estimate $0.605384333B
Annual EPS Estimate
Fiscal Period Ending EPS Estimate Forward PE Low High # of Analysts
Dec 2027 5.25 17.54 5.12123 5.79102 1
Dec 2026 4.53 20.33 4.41488 4.67198 1
Quarterly EPS History
Period EPS Beat / Miss Revenue YoY Beat / Miss
FQ4 2024 (Dec 2024) -0.62 -1.7595 0.598052B 4.56% 16.74M
FQ3 2024 (Sep 2024) 1.27 0.01534 0.587671B 5.35% 12.98M
FQ2 2024 (Jun 2024) 2.01 0.66741 0.591187B 6.46% -382.23M
FQ1 2024 (Mar 2024) 1.22 0.02 0.571414B 2.63% -104.78M
FQ4 2023 (Dec 2023) 1.2 1.2 0.570788B 1.53% 570.79M
FQ3 2023 (Sep 2023) 0.8 0.8 0.556237B -0.31% 556.24M
FQ2 2023 (Jun 2023) -2.46 -2.46 0.552968B -0.89% 552.97M
FQ1 2023 (Mar 2023) 0.78 0.78 0.556389B 100% 556.39M
Quarterly Estimates Summary

FQ4 Announce Date

03/30/2025 (Pre-Market)

Consensus EPS Estimates

1.08

Consensus Revenue Estimates

0.605384333B

Consensus EPS Estimates
Fiscal Period Ending EPS Estimate YoY Growth(%) Low High # of Analysts
FQ4 2026 (Dec 2026) 1.29216 -- 1.27197 1.31825 4
FQ3 2026 (Sep 2026) 1.34658 -- 1.32554 1.37377 3
FQ2 2026 (Jun 2026) 1.51063 -- 1.48702 1.54113 4
FQ1 2026 (Mar 2026) 1.25636 -- 1.23673 1.28173 3
FQ4 2025 (Oct 2025) 1.22 150.82 1.20144 1.24537 4
FQ3 2025 (Jul 2025) 1.3125 3.24 1.29253 1.33979 6
FQ2 2025 (Jun 2025) 1.28667 -56.22 1.26488 1.31965 3
FQ1 2025 (Mar 2025) 1.08 -12.96 1.06171 1.10768 3
Consensus Revenue Estimates
Fiscal Period Ending Revenue Estimate YoY Growth(%) Low High # of Analysts
FQ4 2026 (Dec 2026) 0.69B -- 0.69B 0.7B 3
FQ3 2026 (Sep 2026) 0.68B -- 0.67B 0.69B 3
FQ2 2026 (Jun 2026) 0.67B -- 0.67B 0.68B 4
FQ1 2026 (Mar 2026) 0.66B -- 0.65B 0.67B 5
FQ4 2025 (Oct 2025) 0.62B 3.13 0.61B 0.63B 3
FQ3 2025 (Jul 2025) 0.61B 3.65 0.6B 0.62B 5
FQ2 2025 (Jun 2025) 0.61B 3.55 0.6B 0.63B 2
FQ1 2025 (Mar 2025) 0.61B 5.61 0.6B 0.62B 2
Quarterly Estimates Revisions

EPS # of Up Revisions

4

EPS # of Down Revisions

4

Revenue # of Up Revisions

6

Revenue # of Down Revisions

3

Consensus EPS Revision Trend
Fiscal Period Ending EPS Estimate YoY Growth Low High # of Analysts
FQ4 2021 (Dec 2021) 0.41 -12.52% 0.39 0.48 20
FQ1 2022 (Mar 2022) 0.59 6.89% 0.55 0.62 15
FQ2 2022 (Jun 2022) 0.70 2.62% 0.61 0.74 15
FQ3 2022 (Sep 2022) 0.68 4.62% 0.65 0.70 15
Consensus Revenue Revision Trend
Fiscal Period Ending EPS Estimate YoY Growth Low High # of Analysts
FQ4 2021 (Dec 2021) 0.41 -12.52% 0.39 0.48 20
FQ1 2022 (Mar 2022) 0.59 6.89% 0.55 0.62 15
FQ2 2022 (Jun 2022) 0.70 2.62% 0.61 0.74 15
FQ3 2022 (Sep 2022) 0.68 4.62% 0.65 0.70 15
Earnings Surprise Summary

EPS # of Beats

6

EPS # of Misses

2

EPS # of in-lines

0

Revenue # of Beats

6

Revenue # of Misses

2

Revenue # of in-lines

0

Earnings Surprise (EPS) - Actual vs Consensus
Earnings Date EPS Estimate EPS Actual Surprise Surprise %
FQ4 2024 (Dec 2024) 1.1395 -0.62 -1.7595 283.79%
FQ3 2024 (Sep 2024) 1.25466 1.27 0.01534 1.21%
FQ2 2024 (Jun 2024) 1.34259 2.01 0.66741 33.2%
FQ1 2024 (Mar 2024) 1.2 1.22 0.02 1.64%
FQ4 2023 (Dec 2023) 1.2 1.2 100%
FQ3 2023 (Sep 2023) 0.8 0.8 100%
FQ2 2023 (Jun 2023) -2.46 -2.46 100%
FQ1 2023 (Mar 2023) 0.78 0.78 100%
Revenue Surprise - Actual vs Consensus
Earnings Date Revenue Estimate Revenue Actual Surprise Surprise %
FQ4 2024 (Dec 2024) $0.58B $0.6B $16.74M 2.8%
FQ3 2024 (Sep 2024) $0.57B $0.59B $12.98M 2.21%
FQ2 2024 (Jun 2024) $0.97B $0.59B $-382.23M -64.65%
FQ1 2024 (Mar 2024) $0.68B $0.57B $-104.78M -18.34%
FQ4 2023 (Dec 2023) $0B $0.57B $570.79M 100%
FQ3 2023 (Sep 2023) $0B $0.56B $556.24M 100%
FQ2 2023 (Jun 2023) $0B $0.55B $552.97M 100%
FQ1 2023 (Mar 2023) $0B $0.56B $556.39M 100%
Unlock